Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chagas disease. American trypanosomiasis

L V Kirchhoff1

  • 1Department of Internal Medicine, University of Iowa, Iowa City.

Infectious Disease Clinics of North America
|September 1, 1993
PubMed
Summary

Chagas disease, caused by Trypanosoma cruzi, affects many in Latin America and immigrants in the US. Improved diagnostics and treatments are crucial, especially for immunosuppressed individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regionally limited or rare infections: prevention after hematopoietic cell transplantation.

Bone marrow transplantation·2009
Same author

Cell cycle expression of histone genes in Trypanosoma cruzi.

Molecular and biochemical parasitology·2001
Same author

Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma.

Journal of the American Veterinary Medical Association·2001
Same author

Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery.

Circulation·2000
Same author

Differential expression of GP63 genes in Trypanosoma cruzi.

Molecular and biochemical parasitology·2000
Same author

[Chronic Chagas disease--an echo from youth].

Ugeskrift for laeger·2000

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Public Health

Background:

  • Chagas disease, caused by Trypanosoma cruzi, is a significant health concern in Latin America.
  • Increasing immigration to the United States raises the risk of transfusion-associated Trypanosoma cruzi transmission.
  • Current diagnostic and treatment options for Chagas disease are limited and pose challenges.

Purpose of the Study:

  • To highlight the need for improved diagnostic assays for chronic Trypanosoma cruzi infections.
  • To address the limitations of current drug treatments for Chagas disease, including side effects and efficacy.
  • To emphasize the particular severity of Trypanosoma cruzi infection in immunosuppressed patients.

Main Methods:

  • This abstract does not detail specific methods.
  • Focuses on the clinical and epidemiological aspects of Chagas disease.
  • Highlights the need for advancements in serologic testing and therapeutic interventions.

Main Results:

  • Chagas disease remains a major cause of illness and death in endemic regions.
  • The presence of infected immigrants in the US presents a risk for transfusion-associated transmission.
  • Existing treatments for Trypanosoma cruzi infection are suboptimal.

Conclusions:

  • There is a critical need for the development of enhanced serologic assays for diagnosing chronic Chagas disease.
  • Effective and safer drug treatments are required to manage Trypanosoma cruzi infections.
  • Special attention and improved management strategies are necessary for immunosuppressed individuals with Chagas disease.

Related Experiment Videos